Nizofenone administration in subarachnoid hemorrhage
Completed
Phase N/A ResultsSummary of Purpose
To evaluate the effects of nizofenone in patients with subarachnoid hemorrhage.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 11 April 2001.
| Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Start Date | First Received | 1st Completion | Completion | Verification | Results |
|---|
Trial Design
Multi-center, placebo-controlled, double-blind trial of 208 patients at 30 centers.
Contacts
Not available
Recruitment
- Gender: Both
- Study Size: 208
- Number of Centers: 30
- Max Time from Onset: 14 Days
- Follow Up: 1 Months
Principal Investigator
-
Tomio Ohta, M.D.
Department of Neurosurgery, Osaka Medical School, Osaka, Japan.
